
Amanika Kumar
Professor of Obstetrics and Gynecology · Mayo Clinic College of Medicine and Science
Credentials: · · · ·
History

focus on novel therapeutics for HER2+ breast cancer Yale University
- 2011–2015
OB/GYN Stony Brook University Hospital

Research
The senescence-associated secretome as an indicator of age and medical risk
JCI Insight · 2020 · 334 citations
Tumorgrafts as in vivo surrogates for women with ovarian cancer
Clinical Cancer Research · 2014 · 164 citations
Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer
Gynecologic Oncology · 2017 · First of 8 authors · Corresponding · 113 citations

48 papers

44 papers

26 papers

25 papers

22 papers

20 papers
- AJ
12 papers

11 papers
Clinical trials
- 2025
Principal investigator · Completed
Mayo Clinic
- 2024–2026
Principal investigator · Completed
Mayo Clinic
- 2021–2025
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Principal investigator · Completed
Mayo Clinic
- 2024–2029
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
Site PI · Recruiting · Phase 3
NX Development Corp


